Login

Financial Snapshot

Revenue
TTM
$0.00
Gross Margin
Last 4 Quarters
N/A
Net Income
TTM
-$622.2K
Current Assets
2025 Q4
Current Liabilities
2025 Q4
Current Ratio
2025 Q4
0.0%
Total Assets
2025 Q4
Total Liabilities
2025 Q4
Book Value
2025 Q4
-$8.154M
Cash
2025 Q4
P/E
Last 4 Quarters
N/A
Free Cash Flow
TTM
-$188.2K

Stock Price

Loading...
Market Cap: $46.857 Thousand

About Pineapple Express Cannabis Co

Pineapple Express Cannabis Co (OTC: PNXP) is a cannabis-sector company incorporated in Nevada that describes itself as an ancillary service provider to the cannabis industry. The company's revenue model, as disclosed in its 10-K for the fiscal year ended January 31, 2025, is not clearly defined in the available filing excerpts, and reported revenue figures are redacted or blank in the financial statements. The company was originally incorporated as Minaro Corp. in Nevada on March 14, 2017, and entered a Share Exchange Agreement with Pineapple Consolidated, Inc. (PCI), a California corporation, on December 18, 2022. As of the fiscal year ended January 31, 2025, the company reported a stockholders' deficit and a net loss from operations, with no material revenue disclosed. A second Share Exchange Agreement was referenced in a Form 8-K filed March 11, 2025. Matthew Feinstein, a control person and director, resigned February 12, 2025. The company is headquartered in Los Angeles and trades on the OTC Link alternative quotation system. The filing also references involvement in cannabis and cryptocurrency sectors.

Revenue model
The 10-K for fiscal year ended January 31, 2025 does not disclose a clearly operational revenue model. Revenue figures in the financial statements are redacted or zero, and the company reported a net loss from operations for both fiscal years ended January 31, 2025 and January 31, 2024. A loss on sale of ownership interest in PCI was recorded in a prior period.
Products and services
The filing references ancillary services to cannabis industry operators, including potential medical and adult-use cannabis product offerings and dispensary services, but no specific products, brands, or active service lines with associated revenue are disclosed in the fiscal year ended January 31, 2025 filing excerpts.
Customers and end markets
The filing references cannabis licensees, dispensary operators, and consumers in medical and adult-use cannabis markets as intended end markets, but discloses no active customer relationships, customer counts, or revenue from customers for fiscal year ended January 31, 2025.
Value-chain role
Described in the filing as an ancillary service provider to cannabis industry participants, not a direct cultivator or retailer, though no active service contracts or revenue-generating operations are evidenced in the fiscal year ended January 31, 2025 excerpts.
Geographic exposure
Headquartered in Los Angeles, California. Operations are described in the context of U.S. state-level cannabis regulations. No specific state markets or geographic revenue breakdown is disclosed in the fiscal year ended January 31, 2025 filing.

Source: SEC 10-K, filed 2025-05-16

Industry: Services-Prepackaged Software

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support